Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Szechwan Lovage Rhizome Biod Magnolia Bud Taiwan Angelica Root Wild Mint Herb Baikal Skullcap Root And Borneol

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Szechwan Lovage Rhizome Biod Magnolia Bud Taiwan Angelica Root Wild Mint Herb Baikal Skullcap Root And Borneol1
  • Edible Caramel1

Active Sponsors

  • Taichung Veterans General Hospital1

Top Investigators

Related Conditions

  • Rhinitis Allergic1
  • Medicine Chinese Traditional1

Activity Timeline